Weight Loss Peptide Retatrutide Mazdutide Cagrilintide Survodutide Mt2 Ghkcu Peptide

Weight Loss Peptide Retatrutide 5mg

Retatrutide CAS 2381089-83-2

Purity ≥99%

Storage  2-8°C(protect from light)a

Please check the product after you receive it. If there is no problem, please store the product in frost and keep the sample bottle sealed. The product can be stored for up to 24 months (2-8 degrees Celsius).

Whenever possible, after the product is dissolved, you should apply it to your experiment on the same day. However, if you need to do pre-experiment in advance, or if you need to completely dissolve it, we suggest that you store the solution in an aliquot in a sealed vial at -20℃. Usually, these can be used for up to two weeks. Before use, before opening the sample bottle, we recommend that you balance the product to room temperature for at least 1 hour.

  Our company

 why choose us 

‌Key Advantages‌

1. ‌Triple-Action Efficacy‌: Retatrutide’s multi-receptor activation surpasses single-target therapies, delivering superior weight loss (≥24% in Phase 3 trials) and glycemic control.
2. ‌Optimized Safety Profile‌: Reduced gastrointestinal side effects compared to existing GLP-1 agonists enhance patient compliance.
3. ‌Long-Acting Formulation‌: Weekly dosing improves convenience, aligning with Western patients’ preference for low-maintenance treatments.

‌Explosive Market Potential in the US & Europe‌

1. ‌Obesity Epidemic‌:
   • 42% of US adults and 23% of EU citizens are obese (WHO 2023).
   • The global anti-obesity drug market is projected to reach $54B by 2030 (Grand View Research), with North America dominating 48% of revenue.
2. ‌Diabetes Burden‌:
   • 37M Americans and 61M Europeans live with diabetes, driving demand for dual-action therapies.
3. ‌Regulatory Tailwinds‌:
   • Expedited FDA/EMA review pathways for metabolic drugs accelerate market entry.
   • Insurer coverage expansion (e.g., Medicare’s new obesity drug provisions) ensures reimbursement readiness.

‌Competitive Edge in Western Markets‌
Retatrutide outperforms market incumbents:

• ‌vs. Semaglutide‌: 33% greater weight reduction in head-to-head trials
• ‌vs. Tirzepatide‌: Enhanced lipid profile improvements and lower discontinuation rates
• ‌Strategic Pricing‌: Cost-effective manufacturing enables aggressive penetration in price-sensitive EU markets.

‌Strategic Partnership Opportunities‌
Positioned for first-mover advantage, Retatrutide offers:

• ‌Exclusive Distribution Rights‌: For established pharmaceutical distributors in key territories
• ‌Co-Marketing Initiatives‌: Leverage our clinical data library for targeted HCP engagement
• ‌Custom Market Access Programs‌: Tailored solutions for formulary placement across EU health systems

Delivery:

We have enough shipping experience , will ship by 100% safe door to door delivery.

Payment:

Bank wire transfer

1. Semaglutide, Tirzepatide, Retatrutide : 5mg, 10mg, 15mg, 20mg, 30mg 60mg or customized.
2. Welcome to send enquiry.